" "
Satellite Banner
Informatics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Kalorama Estimates Orphan Drug Market Will Expand 11.5% Annually Through 2017

Published: Wednesday, April 02, 2014
Last Updated: Tuesday, April 01, 2014
Bookmark and Share
Report looks at market trends and provides in-depth market data for the U.S., along with estimates for the market opportunity in Europe, Japan and globally.

The world orphan drug market reached $61 billion in 2012, according to Kalorama Information's research. Incentives have created a thriving market, and the increasing incidence of diseases affecting the elderly will drive the market to expand at a rate of 11.5% annually through 2017. Learn about the latest developments and opportunities in this important market in their detailed report:
"The World Market for Orphan Drugs (Markets for Oncology, Hematology, Neurology, Endocrine, Metabolic and Other Drugs)".

In recent years, there has been a substantial increase in the number of drugs available to treat rare ("orphan") diseases, which are eligible for development incentives. In the U.S., a drug may be designated an orphan drug if the disease or condition for which it is indicated affects less than 200,000 Americans. Pharmaceutical companies have seen an opportunity in developing these orphan drugs with reduced regulatory costs and incentivized development.

This comprehensive report looks at market trends and provides in-depth market data for the U.S., along with estimates for the market opportunity in Europe, Japan and globally. With over 400 pages of market analysis and over 120 figures and tables, the report provides in-depth coverage of key competitors and important trends and challenges for makers of orphan drug treatments.

The following segments are discussed:
Oncology
Hematology
Musculoskeletal
Neurology
Endocrine
Metabolic
Others
Analysis of the "Pure" Orphan Drug Market:

The world orphan drug market is difficult to determine due to variances in orphan drug status and requirements by country. Some publicized estimates of orphan drug markets include brand revenue that is not truly related to the orphan status of the drug. In The World Market for Orphan Drugs, Kalorama Information separates strictly orphan revenue from total brand revenue where necessary to provide a true picture of the pure orphan drug market opportunity.

Demographics, Costs, Regulation and Other Trends Examined:

The list of trends and factors affecting the orphan drug market remain lengthy. It is affected both by trends that affect the pharmaceutical industry as a whole and trends that specifically affect the orphan drug market:
Orphan drug pricing
Aging of the population
Increasing life expectancy
Trends in birth rates
Cost effectiveness
Regulatory environments
Orphan drug incentives
Population demographics
Product availability by country/region
Extensive Company Coverage:

The World Market for Orphan Drugs looks extensively at what major pharmaceutical companies and smaller concerns are doing within this drug category and profiles over 45 companies. Company market share for both the US and global markets is provided. A variety of companies with both designations and designation/approvals are discussed.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,900+ scientific posters on ePosters
  • More than 4,200+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Laboratory Information Systems (LIS / LIMS) 2013-2017
Report analyzes the current and potential world markets for medical laboratory information system software and hardware
Saturday, June 14, 2014
New Market Research Report on Laboratory Information Systems (LIS / LIMS) Markets
New industry report profiles several companies, including large companies that have made names for themselves in the field, as well as smaller firms with market niches
Wednesday, April 16, 2014
Kalorama Releases Report on Lab Automation Markets
Report highlights updates since previous edition: new systems that have been introduced, market share shifts and industry alliances and mergers.
Saturday, November 23, 2013
Kalorama Releases LIMS/LIS Report
Report profiles more than 50 LIMS/LIS vendors
Sunday, November 10, 2013
Industry Report States Molecular Diagnostics Driving LIMS Industry
LIMS market predicted to grow to nearly a 1.5 billion-dollar market in 2015
Tuesday, October 01, 2013
Scientific News
‘Lifespan Machine’ Probes Cause of Aging
Findings suggest that aging has no single mechanism.
Machine Learning Uncovers Unknown Bacterial Features
Technique robustly identified characteristic gene expression patterns in response to antibiotics, low oxygen conditions.
Nucleic Acid Computing Inside Cells
Using strands of nucleic acid, scientists have demonstrated basic computing operations inside a living mammalian cell.
Risk Map for Nematode Parasite in Uganda
Infection with the nematode parasite Mansonella perstans is one of the most neglected of the neglected tropical diseases.
DNA Analysis in the Fast Lane
Rice bioengineers' method should lead to better database of thermal behaviors.
Mapping out Cell Conversion
Researchers develop algorithm that takes the field of cell reprogramming forward.
Parallel Single-Cell Profiling
New single-cell genomics protocol allows researchers to study links between DNA modifications (methylation) and the activity of a gene.
ASCB: A CELLebration of Cell Biology
The last major congress of the year, ASCB is less a platform for launching new products, but one for confirming and consolidating the trends that have emerged over the past 12 months.
Three Glaucoma-Related Genes Discovered
NIH-funded genetics analysis of glaucoma is largest to date.
Milestone Resource in Wheat Research Now Available for Download
Leading on from The Genome Analysis Centre’s (TGAC) previous announcement of their new bread wheat genome assembly, the landmark resource is now publically available to download at the European Bioinformatics Institute’s (EMBL-EBI) Ensembl database for full analysis.
Scroll Up
Scroll Down
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!